Trasylol Attorneys

Serving Philadelphia, Pennsylvania, New Jersey, Delaware, New York & Nationwide

Use of the drug Trasylol, or aprotinin, during heart surgery has been associated with an increased risk of kidney failure, heart attack, stroke and resulting death, according to studies.

One study reported in February 2007 found that Trasylol, used to reduce internal bleeding during surgery, was associated with a 48 percent increase in deaths within five years of bypass surgery. The observational study by researchers in California included 3,876 patients who underwent coronary bypass surgery.

On Nov. 5, 2007, the U.S. Food and Drug Administration announced that manufacturer Bayer Pharmaceuticals was suspending Trasylol from the market.

A report by the CBS news show 60 Minutes aired in February 2008 quoted a researcher who estimated that 22,000 patients -- or some 1,000 every month -- could have been saved if the FDA had removed Trasylol when his initial study showed a link between the drug and increased death rates two years earlier. (Full 60 Minutes report.)

A study published in January 2006 in The New England Journal of Medicine noted double the risk of renal failure among patients given Trasylol, which was approved by the FDA in 1993. That study also found a 55 percent increase in heart attacks and heart failures and nearly double the incidence of stroke or encephalopathy among patients given Trasylol.

The study was conducted by the non-profit Ischemia Research and Education Foundation in San Bruno , Calif. It concluded: “The association between aprotinin and serious end-organ damage indicates that continued use is not prudent.”

Bayer continued to maintain that Trasylol is “safe and effective treatment” and disputed the study as inconsistent with the company’s own clinical data and experience with the drug.

The study included 4,374 patients who were given aprotinin, a placebo and two other drugs used to control bleeding, aminocaproic acid and tranexamic acid, both generic drugs. The other drugs did not exhibit the same problems and were deemed by the study as safer and far less expensive.

In an editorial that accompanied the study report, Dr. Gus J. Vlahakes of the Harvard Medical School and the acclaimed Massachusetts General Hospital wrote: “Some surgeons and anesthesiologists who use the drug have been concerned about its potential risks since it was first approved for clinical use; yet until the recent report … sufficient data have not been available for an analysis of the risks and benefits of aprotinin.”

Kline & Specter,PC, with more than 40 attorneys, several of whom are also highly regarded doctors, has broad expertise and experience in pursuing pharmaceutical injury claims. Our law firm, based in Philadelphia and serving the Pennsylvania-New Jersey-Delaware region as well as clients nationwide, has produced superb results in a large number of personal injury cases. Contact a Trasylol lawyer - aprotinin lawyer today.

News

On a 60 Minutes report, a researcher estimated that 22,000 patients could have been saved -- or about 1,000 per month -- if the FDA had removed Trasylol earlier. (Full story)

Excess 30-day mortality in the Trasylol (aprotinin) arm of an ongoing heart surgery trial discovered by an interim safety analysis has forced researchers to shut down the aprotinin arm of the trial.

Trasylol, used to control internal bleeding in heart surgery patients, increases the risk of kidney failure, according to a study reported in the New England Journal of Medicine.(Full story)

We have more $10 million+ results over a 20-year period than any other Pennsylvania law firm, as many as the next three firms combined.The Legal Intelligencer

2

We Care About You

We work closely with you to help ensure you receive every bit of legal, medical, insurance and financial assistance to which you are entitled.

3

Best Attorneys

Seventeen of our attorneys have been named Super Lawyers or “Rising Stars” by the independent rating survey. Tom Kline has been rated No. 1 in PA 15 times in a row and Shanin Specter in the Top 10 year after year.

4

Doctor/Lawyer Team

We have an unmatched staff of five doctor-lawyers working full-time for our firm. No other law firm in the United States has as many physicians on staff.

5

Our Staff

We have more than 40 attorneys and a staff of 110 to serve clients. We promptly pair you with an attorney for a consultation and spare no effort or expense in litigating cases.

6

Legal Care

We are leaders in handling serious personal injury & whistleblower cases. When we go to court, we bring an army of skilled attorneys and experts to seek to achieve the best possible verdict or settlement.

7

Safety Efforts

We care about making things right. In a lot of cases, that means getting you more than just money. Our cases have resulted in safety improvements in medical care, consumer products, mass transit, motor vehicles, public utilities, police conduct and more.

8

Free Consultations

We provide free case reviews and we work on a contingent fee basis, meaning we don’t get paid unless you win.

Search Video and Print Articles

Select from one or more categories to find videos of Kline & Specter in the media.

Practice Area

Sub Category

Case

Attorney

Major Victories

$153M

Verdict against Ford in death of a boy run over by truck with defective parking brake. The then-second largest product liability verdict in the nation. (White) (Jury awarded $52 million in retrial of punitive damages.)

$109M

Largest contested liability personal injury verdict in Pennsylvania history, including $48 million compensatory and $61 million punitive damages for the family of a woman killed by a fallen electric line. (Goretzka)

$100M

Largest-ever medical malpractice verdict in Pennsylvania, for a baby who suffered severe brain damage due to medical malpractice. (Vlasny)

$96M

Recovery following a verdict for a woman catastrophically injured in a Philadelphia building collapse. Largest personal injury recovery in Pennsylvania history. (Plekan)

Verdict against the Philadelphia mass transit agency in a case in which a boy’s foot was severed in an escalator. SEPTA was also fined for concealing documents. (Hall)

$49M

Verdict in a hospital error case that left a young man severely brain damaged. The award set a Pennsylvania record at the time for a medical malpractice case. (Caruso)

$47M

Largest medical malpractice verdict in federal court in Pennsylvania history, for a child injured in a post-birth procedure. (Harker/Baldacchino)

$47M

Jury verdict – $8.02 million compensatory and $38.5 million punitive – against a security company for the families of two women killed by a disgruntled employee at Kraft Foods plant in Philadelphia. (Brown/Wilson)

Kline & Specter handles cases in Pennsylvania, New Jersey, Delaware and New York. For cases outside those states, Kline & Specter works with local attorneys in each state as applicable.

Kline & Specter, PC only provides legal advice after having entered into an attorney client relationship, which our website specifically does not create. It is imperative that any action taken be done on advice of counsel. Because every case is different, the description of awards and cases previously handled do not guarantee a similar outcome in current or future cases. The firm practices law in New Jersey as Kline & Specter. Super Lawyers, Best Lawyers in America and other organizations that rate attorneys are not designations that have been approved by the State Supreme Courts or the American Bar Association.This website is not intended for viewing or usage by European Union citizens.